Time for a Paradigm Shift in Non-muscle-invasive Bladder Cancer (Volume II)

Dear Colleagues,

This Special Issue is entitled “Time for a Paradigm Shift in Non-muscle Invasive Bladder Cancer” and is available at https://www.mdpi.com/journal/cancers/special_issues/Paradigm_Shift_Bladder_Cancer

Non-muscle-invasive bladder cancer (NMIBC) is a highly varied heterogeneous disease with a variety of treatment modalities and different follow-up regimens. Most cases of NMIBC are treated with TURBT and potential adjuvant instillation therapy, whereas the minority can be treated via radical cystectomy. However, despite the utilization of a variety of treatment modalities over the last few decades, a recurrence rate of more than 50% of all patients highlights the urgent need for the development of a better frontline treatment. Moreover, the decades-old use of piecemeal TURBT in NMIBC violates normal oncological principles and the deployment of life-long follow-up regimens based on traditional pathological risk stratification in a disease that has been studied for decades call for a change.

In this Special Issue of Cancers, we will highlight studies where traditional approaches to NMIBC are questioned and challenged and in which new treatment regimens are investigated.

Prof. Dr. Jørgen Bjerggaard Jensen
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.